COLLABORATIVE INNOVATION

Seeding tomorrow’s priority medicines
Our resources
your results

Drug target & assays
Helping you

to create new medicines

Concept
Our expertise
your creativity

Results

European Lead Factory

Latest news

22 May 2020

In Memoriam: Professor dr. Huib Ovaa

15 May 2020

Study conducted in collaboration with ELF discovers brain compound can blur traumatic memories

12 May 2020

Project member spotlight: Patricia Kramer-Verhulst

Call for proposals

Find out how you can boost your drug discovery programme and submit your screening proposal today

Publications

15 May 2020

Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice

14 January 2020

Identification of A Novel Class of Benzofuran Oxoacetic Acid-Derived Ligands that Selectively Activate Cellular EPAC1.

View all publications

European Lead Factory

Hitting the targets

The video report from the European
Lead Factory (ELF) Stakeholder
Meeting, 25-26 April, 2017 with an exciting agenda focussing on four
years of successful collaboration, the impact of the European Lead Factory
and the future of drug discovery.
View all animations

Events

19 May 2021

All events have currently been put on hold, but make sure to watch this space for future announcements. In the meantime, we remain available for any questions you might have. Feel free to reach out to us at: programme@europeanleadfactory.eu.

View all events

Testimonials

Margit Mahlapuu

Associate Professor in Medicine Inst. of Medicine, University of Gothenburg

https://www.europeanleadfactory.eu/results/testimonials#Margit

Richard Mead, PhD

Sheffield Institute for Translational Neuroscience, University of Sheffield

https://www.europeanleadfactory.eu/results/testimonials#RichardMead

Jan Kulagowski

Drug Discovery Manager- Parkinson's UK

Tweets by EULeadFactory

http://www.merckgroup.com/en/index.html

http://www.janssen.com/

http://www.astrazeneca.com

http://www.bayerpharma.com

http://www.lundbeck.com

http://en.sanofi.com/

http://www.ucb.com

http://www.tarosdiscovery.com

http://www.edelris.com

http://www.sygnaturediscovery.com

http://www.mercachemsyncom.com

http://www.arttic.eu/pages/en/home.php

http://www.lygature.org

http://www.bioascent.com

http://www.chemaxon.com

http://www.lead-discovery.de

http://www.pivotparkscreeningcentre.com

http://www.lifesci.dundee.ac.uk

http://www.leiden.edu

http://www.lumc.nl

http://www.mpi-dortmund.mpg.de

http://www.ru.nl/imm/

http://www.drugdesign.nl

http://www.dtu.dk

http://www.uni-due.de/en/

http://www.asn.leeds.ac.uk

http://www.nottingham.ac.uk/chemistry

http://www.ox.ac.uk

http://www.chem.vu.nl/en/index.asp

https://www.mmv.org/

https://www.grunenthal.com/

http://www.servier.com

© European Lead Factory and its partners.

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n' 115489, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7 / 2007-2013) and EFPIA companies' in kind contribution.

This project has also received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806948: ‘ESCulab: European Screening Centre; Unique Library for Attractive Biology’. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Medicines for Malaria Venture (MMV).